418762-26-2

Basic information

• Product Name: 4-Bromo-2-fluoro-5-methylaniline
• Synonyms: 4-BROMO-2-FLUORO-5-METHYLANILINE 97%;4-Bromo-2-fluoro-5-methylaniline;BenzenaMine,4-broMo-2-fluoro-5-Methyl-;4-Bromo-2-fluoro-5-methyl-phenylamine
• CAS NO: 418762-26-2
• Molecular Formula: C₇H₇BrFN
• Molecular Weight: 204.04
• Mol File: 418762-26-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 229.5°C at 760 mmHg
• Flash Point: 92.6°C
• Appearance: /
• Density: 1.589g/cm³
• Vapor Pressure: 0.0693mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 2.62±0.10(Predicted)
• CAS DataBase Reference: 4-Bromo-2-fluoro-5-methylaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-2-fluoro-5-methylaniline(418762-26-2)
• EPA Substance Registry System: 4-Bromo-2-fluoro-5-methylaniline(418762-26-2)

Safety Data

• Hazardous Substances Data: 418762-26-2(Hazardous Substances Data)

Usage

General Description

4-Bromo-2-fluoro-5-methylaniline is a compound characterized by the presence of specific chemical groups such as bromine, fluorine, and an amino group attached to a benzene ring. The presence of these groups influence the physical, chemical, and biological properties of the compound. Apart from its chemical structure, essential properties like molecular weight, boiling point and heat of vaporization may also be used to describe it. In the context of its applications, this chemical compound is usually utilized as an intermediate in organic synthesis because of the characteristic reactivity provided by the functional group, the amino group. Its use can range from pharmaceuticals, in the synthesis of more complex drug molecules, to other advanced material developments. Despite its potential uses, care should always be taken when handling this compound due to the potential for harmful effects related to exposure or mishandling.

InChI:InChI=1/C7H7BrFN/c1-4-2-7(10)6(9)3-5(4)8/h2-3H,10H2,1H3

Upstream product

• 452-84-6 3-amino-4-fluorotoluene 

Downstream Products

• 939968-22-6 1-(4-bromo-2-fluoro-5-methylphenyl)-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea 
• 1132944-97-8 N-(4-bromo-2-fluoro-5-methylphenyl)methanesulfonamide 
• 1202389-31-8 2-fluoro-5-methyl-4-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)aniline 
• 1243246-11-8 2-fluoro-5-methyl-4-(2-methylpyridin-4-yl)aniline 
• 1332332-77-0 5-{[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl}-4-[2-fluoro-5-methyl-4-(7-quinolinyl)phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one 
• 1332333-77-3 N-(4-bromo-2-fluoro-5-methylphenyl)-2-{[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]acetyl}hydrazinecarboxamide 
• 1386951-27-4 N,N-dibenzyl-4-bromo-2-fluoro-5-methylbenzenamine 
• 1386951-28-5 tert-butyl 4-(4-(dibenzylamino)-5-fluoro-2-methylphenyl)piperazine-1-carboxylate 
• 1386951-29-6 tert-butyl 4-(4-amino-5-fluoro-2-methylphenyl)piperazine-1-carboxylate 
• 1390657-52-9 tert-butyl 4-(4-(7-chloro-4-oxo-3,4-dihydropyrido[3,4-d]pyridazin-5-ylamino)-5-fluoro-2-methylphenyl)piperazine-1-carboxylate 
• 1390657-53-0 tert-butyl 4-(4-(7-(2,6-dichlorobenzyl)-4-oxo-3,4-dihydropyrido[3,4-d]pyridazin-5-ylamino)-5-fluoro-2-methylphenyl)piperazine-1-carboxylate 
• 1390655-92-1 7-(2,6-dichlorobenzyl)-5-{[2-fluoro-5-methyl-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one 
• 916792-13-7 2-fluoro-4-bromo-5-methylbenzonitrile 
• 874804-14-5 4-bromo-2-fluoro-5-methylbenzene-1-sulfonyl chloride 

Relevant articles and documents

METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS

Provided are methods for expanding stem cells and/or lineage committed progenitor cells, such as hematopoietic stems cells and/or lineage committed progenitor cells, at least in part, by using compounds that antagonize AhR. The compounds are represented by formulae (I) (II) (III) (IV), wherein the letters and symbols a, b, c, d, e, f, g, Z, R1b, R2a and R2b have the meanings provided in the specification. Also provided are compositions comprising stem cells and/or lineage committed progenitor cells expanded by methods disclosed herein and methods for the treatment of diseases treatable by same.

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

The present invention provides compounds of Formula (I) and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.